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Abstract Purpose: The aim of
our study was to explore, using an
innovative method, the effect of
temporal changes in the mortality
prediction performance of an existing
model on the quality of care assess-
ment. The prognostic model (rSAPS-
II) was a recalibrated Simpliﬁed
Acute Physiology Score-II model
developed for very elderly Intensive
Care Unit (ICU) patients. Meth-
ods: The study population
comprised all 12,143 consecutive
patients aged 80 years and older
admitted between January 2004 and
July 2009 to one of the ICUs of 21
Dutch hospitals. The prospective
dataset was split into 30 equally sized
consecutive subsets. Per subset, we
measured the model’s discrimination
[area under the curve (AUC)], accu-
racy (Brier score), and standardized
mortality ratio (SMR), both without
and after repeated recalibration. All
performance measures were consid-
ered to be stable if\2 consecutive
points fell outside the green zone
[mean ± 2 standard deviation (SD)]
and none fell outside the yellow zone
(mean ± 4SD) of pre-control charts.
We compared proportions of hospi-
tals with SMR[1 without and after
repeated recalibration for the year
2009. Results: For all subsets, the
AUCs were stable, but the Brier
scores and SMRs were not. The SMR
was downtrending, achieving levels
signiﬁcantly below 1. Repeated
recalibration rendered it stable again.
The proportions of hospitals with
SMR[1 and SMR\1 changed from
15 versus 85% to 35 versus 65%.
Conclusions: Variability over time
may markedly vary among different
performance measures, and infre-
quent model recalibration can result
in improper assessment of the quality
of care in many hospitals. We stress
the importance of the timely recali-
bration and repeated validation of
prognostic models over time.
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Introduction
Prognostic models have been promoted as helpful tools to
support health care professionals in the clinical manage-
ment of their patients, both as individuals and as groups [1,
2]. In the ﬁeld of intensive care, there is a long tradition of
developing prognostic models of mortality for bench-
markingamongIntensiveCareUnits(ICU)forpurposesof
quality of care assessment [3, 4]. For the purpose of
benchmarking, the model’s predictions are adjusted for the
severity of the illness of the patients in each unit and
compared to the respective observed mortality rates.
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requires that the user trusts the models. This trust is in
turn dependent upon external validation of the model’s
performance. However, external validation studies are
scarce, thereby jeopardizing the use of these models in
clinical practice [5–7]. In addition, the external vali-
dation of a model’s performance often relies on a
single validation dataset, while changes in population
and treatment over time may change the prognosis of
patients and thereby limit the applicability of prog-
nostic models. The aim of this paper is to explore the
effect of variability of the performance measures over
time of an earlier published model [8] on the quality of
care assessment, with and without repeated recalibra-
tion of the model. The model, referred to as rSAPS-II,
was obtained as a customization of the popular Sim-
pliﬁed Acute Physiology Score (SAPS) II model for
predicting mortality in ICU patients aged 80 years or
older [8, 9].
Materials and methods
In this prospective cohort study we monitored, over the
course of time, the predictive performance of the rSAPS-
II model by partitioning the prospective data into 30 time-
ordered equally sized groups and calculating the perfor-
mance measures per group.
Model
In 2007 we reported on a prognostic model that predicts
the mortality risk for ICU patients aged 80 years and
older [8]. The dataset consisted of 6,867 ICU admissions
between January 1997 and December 2003, of which two-
thirds (N = 4,578) and one-third (N = 2,289) were ran-
domly selected for with the aim of developing and
validating, respectively, the model. The admissions orig-
inated from mixed medical and surgical ICU of 21
university, teaching, and non-teaching hospitals in the
Netherlands that participated in the National Intensive
Care Evaluation (NICE) registry [10].
This rSAPS-II model was obtained by recalibrating
the SAPS-II model [9], which was developed for a
general adult ICU population, using the developmental
dataset. The model was recalibrated by reﬁtting its
coefﬁcients [8]. The linear predictor of the rSAPS-II
model is: -3.623 ? 0.073 9 SAPS-II - 0.089 9
log(SAPS-II ? 1) where SAPS-II indicates the severity
score. The model’s performance in terms of the area
under the receiver operating characteristic curve (AUC)
and Brier score [± standard deviation (SD)] on the
validation set are 0.77 (±0.01) and 0.16 (±0.01),
respectively.
Prospective data for temporal validation
Data for prospectively validating the model over time
included all 12,143 consecutive admissions of patients
aged 80 years and older between January 2004 and July
2009 (at which time the number of beds and of patient
admissions had increased) (Table 1). These data were
obtained from the 21 original ICUs. Because the model
was already published, the timing of temporal validation
was naturally set, and at the same time we had total access
to the data in the previous period [11]. The NICE registry,
which incorporates a framework for maintaining a high
quality of data [10], includes demographic data and data
necessary to calculate SAPS-II, as well as survival status
in the ICU and hospital.
Performance measures
We used the AUC as a discrimination measure between
survivors and non-survivors (the larger the AUC the
better) and the Brier score as a measure of inaccuracy (the
lower the score the better) [Electronic Supplementary
Material (ESM)] [12]. Our third measure was the stan-
dardized mortality ratio (SMR) [13], which is the
observed number of deaths divided by the case mix-
adjusted predicted number of deaths. As the SMR indi-
cates how close predicted mortality is to the observed
mortality, it can be applied in two ways: (1) the overall
SMR of all hospitals is a measure of model calibration
(1.0 = perfect calibration; \1.0 = over-prediction of
mortality;[1.0 = under-prediction of mortality), and (2)
the individual SMR of each hospital is a measure of the
hospital’s delivered quality of care (1.0 = expected
Table 1 Patient characteristics in the developmental, temporal and
external datasets
Patient characteristics Internal
validation set
a Temporal
validation set
N 2,289 12,143
Age (range) 80–103 80–108
Age (mean ± SD) 83.5 ± 3.6 82.5 ± 13.7
Male (%) 48.0 50.2
Died (%) 30.5 32.0
APACHE II score (mean ± SD) 18.4 ± 7.2 19.1 ± 7.4
SAPS II score (mean ± SD) 41.6 ± 17.2 43.9 ± 17.4
LOS ICU [days; (median (IQR)] 1.1 (0.8–3.2) 1.4 (0.8–3.7)
Admission type (%)
Medical 33.8 38.7
Unplanned surgery 19.3 20.0
Planned surgery 46.8 41.3
SD Standard deviation, APACHE Acute Physiology And Chronic
Health Evaluation, SAPS Simpliﬁed Acute Physiology Score, LOS
ICU Length of stay in the Intensive Care Unit, IQR inter-quartile
range
a Used in de Rooij et al. [8]
41quality of care; \1.0 = better care than expected;
[1.0 = poorer care than expected). As time passes, the
SMR can be inﬂuenced by changes over time in both the
quality of care delivered and in patient mix. Therefore,
the overall SMR will tend to be closer to 1 in the
immediately prospectively collected validation sets than
those collected later in time. However, if we use a model
with an overall SMR that deviates from 1.0 (meaning the
model is poorly calibrated), the individual SMRs calcu-
lated on the basis of this model will provide an incorrect
view of the delivered quality of care.
Time-series analysis
Performance measures were scrutinized using statistical
process control (SPC; ESM). We split our dataset into 30
consecutive subsets of equal size Ng and calculated the
performance measures described above for each set. The
number of groups was chosen to be 30 because (1) the
groups were still of sufﬁcient size (C400 admissions per
group) and (2) the series was large enough to allow per-
formance measures to be scrutinized over time. Group
sizes were ﬁxed such that their means were based on the
same numbers of patients (time periods were still simi-
lar—between 2 and 3 months in each group). We used
pre-control charts (also known as zone charts) which
allow users to pre-specify the limits of three zones and
which are intuitive by their ‘‘trafﬁc light’’ design: the
process is said to be stable if all points fall within the
green (safe) zone, no two consecutive points fall within
the yellow (warning) zone, and no points fall within the
red (critical) zone [14]. An unstable process in SPC refers
to a statistically signiﬁcant change at the 0.05 level [14].
We deﬁned our zones by mean values ± 2 SD (green
zone), 2–4 SD (yellow zone), and [4 SD (red zone).
Mean values and standard deviations of the performance
measures were calculated based on the internal validation
set (N = 2,289) from the previous period. Speciﬁcally,
the performance measure statistics were calculated by
taking 3,000, possibly overlapping, samples of size Ng
from this dataset. For each sample we ﬁrst calculated the
performance measure of interest and then calculated the
mean and standard deviation of these 3,000 values. These
values were used to determine the central and control
limits in the pre-control charts. In addition, to obtain
insight into changes in the case-mix over time we plotted
a regular graph of the original SAPS-II score, mean age,
and mortality rates in the 30 groups.
Effect on quality of care assessment and recalibration
In the NICE registry [10], hospitals are annually ranked
based on their individual SMR, which is used as a key
measure of their delivered quality of care. To estimate the
effect of prognostic model performance on the quality of
care assessment, we calculated the individual SMR of
each hospital for the last year, 2009, based on several
rSAPS-II models that had been recalibrated on data of
earlier years. Speciﬁcally, we obtained ﬁve models by
using ﬁrst-level recalibration (ESM) of the rSAPS-II
model on the following datasets, but now used as devel-
opmental sets: 1997–2004, 1997–2005, 1997–2006,
1997–2007, and 1997–2008.
To explore the effect of repeated recalibration on
the overall SMR, we recalibrated rSAPS-II for each
time point p in the 30-point time-series on the dataset
from 1997 until the period just preceding p. The model
was then prospectively evaluated on the dataset at time
point p.
Results
Figures 1 and 2 show the behavior of the performance
measures over the course of time. The AUC and Brier
graphs in Figs. 1 and 2 both show no signs of instability:
with the exception of two non-consecutive measure-
ments in the yellow zone, all measurements remain
inside the green zone. In the SMR graph shown at the
top of Fig. 3, all measurements until the 23rd measure-
ment remain inside the green zone; thereafter, however,
the SMR is clearly unstable: four consecutive measure-
ments fall within the lower yellow zone and after two
consecutive measurements in the green zone, two con-
secutive measurements once again fall within the yellow
zone. A downward trend is clearly visible, and eight
measurements are signiﬁcantly \1.0, as illustrated by
their 95% conﬁdence intervals. Although ﬂuctuating
around their mean values, AUCs, Brier scores, and
SMRs all show some relatively large jumps in conse-
quent values. For example, the AUC changed from
0.75 at measurement 25 to 0.81 at the following
measurement.
The graph at the bottom of Fig. 3 shows that after
repeated recalibration of rSAPS-II, all overall SMRs from
the 23rd measurement onward remain inside the green
zone, with none signiﬁcantly\1. The graph at the middle
of Fig. 3 shows the behavior of the original SAPS-II score
over time. On the whole, the series of severity of illness
score shows a positive trend, while mortality and mean
age do not show any trend over time (Figs. 4, 5). The
implications of repeated recalibration can be shown by
measuring its effects on the SMRs of individual hospitals.
Based on the rSAPS-II model without any further recal-
ibration, three of 20 hospitals in 2009 (15%) were
assessed to deliver poorer care than expected according to
their SMR (SMR[1), while the other 17 (85%) were
42assessed to deliver better care than average (SMR\1).
After recalibration of the rSAPS-II model on data until
2004, 2005, 2006, 2007, and 2008, the percentage of
hospitals with SMR[1 and SMR\1 gradually changed
to 35 and 65%, respectively (Table 2).
Discussion
The temporal validation of an earlier published model for
predicting mortality risk in elderly ICU patients revealed
Fig. 1 Area under the receiver operating characteristic curve
(AUC) of the rSAPS-II over time. Means and standard deviations
(SD) are based on the bootstrap sample distribution obtained by
taking 3000 samples of size 405 from the internal validation set.
rSAPS-II Model developed for assessing the quality of care based
on the Simpliﬁed Acute Physiology Score (SAPS)
Fig. 2 Brier scores of rSAPS-II over time. Means and standard deviations (SD) are based on the bootstrap sample distribution obtained
by taking 3000 samples of size 405 from the internal validation set
43that signiﬁcant differences appeared over time between
the expected and observed values of the SMR, while the
AUC and Brier score did not show this behavior. One
may expect a gradual deterioration of model performance,
but this trend was only visible in the overall SMR [15,
16]. There was a slight increase in illness severity, as
demonstrated by the original SAPS-II score, but in an
ideal model the overall SMR should not be affected. A
steady decrease of the overall SMR is caused by the
overestimation of mortality, indicating that the model is
outdated. When the quality of care provided by ICUs is
assessed by such a model, a signiﬁcant proportion of the
ICUs would appear to be performing better (SMR\1)
than the norm (SMR = 1), whereas in practice they may
actually be underperforming. Repeated recalibration of
models adequately alleviates these problems.
To the best of our knowledge, this is the ﬁrst published
study exploring a prognostic model’s prospective perfor-
mance repeatedly over the course of time. In an earlier
study [17], Harrison et al. measured the prospective per-
formance of SAPS-II, Acute Physiology Score And
Fig. 3 Standardized mortality ratio (SMR) of rSAPS-II over time. Means and standard deviations (SD) are based on the bootstrap sample
distribution obtained by taking 3000 samples of size 405 from the internal validation set
Fig. 4 Mortality over time
Fig. 5 Mean age over time
Table 2 Percentage of hospitals with a SMR above 1 or below 1
after recalibration
Data used for
recalibration
% of hospitals with
SMR[1.0
% of hospitals with
SMR\1.0
1997–2003 15 85
1997–2004 20 80
1997–2005 25 75
1997–2006 25 75
1997–2007 30 70
1997–2008 35 65
SMR Standardized mortality rate
44Chronic Health Evaluation (APACHE) II and III, and the
Mortality Prediction Model (MPM) II at three different
moments; however, they did not repeat any measurements
nor did they address the policy implications of using the
SMR for assessing the quality of care. We scrutinized the
behavior of three different measures (AUC, Brier score,
and SMR) covering discrimination, accuracy, and cali-
bration performance aspects, but used fewer measures
than Harrison et al. [17]. Mean values and standard
deviations (for setting the zone limits) were obtained from
the previous period, such that all of the prospective data
can be used. Our sampling approach showed no marked
deviations from normality in the performance measure
distributions. Pseudo R
2 measures [1 - Brier score/
overall mortality 9 (1 - overall mortality)], which adjust
for mortality percentage per group, yielded the same
pattern as the Brier score (data not shown). We used 30
prospective groups for analysis, which are ﬁrmly within
the acceptable range of 12–36 groups [14]. We validated
the robustness of our approach by using different numbers
(and hence sizes) of groups, which all yielded the same
patterns (data not shown). The model we investigated was
already published so the start of the temporal validation
was not subject to arbitrary choices. The number of
patients in the temporal validation set was large, and
prospective data collection covered a period of 6 years.
A main limitation of our study is the restriction of the
population to elderly ICU patients. However, this is an
important and growing population, and the rSAPS-II
model was already recalibrated for this population and
had good performance when it was internally validated.
Moreover, our work addresses the applicability of prog-
nostic models in general. The robustness of our approach
could have also been validated more extensively by other
means. For example, it is possible to investigate the
model’s behavior on different proportions of randomly
selected patients in each time interval to inspect the sen-
sitivity of the results to the speciﬁc case-mixes. These
kinds of sensitivity analyses merit future research.
Our ﬁndings signify the caveats of not timely cali-
brating prognostic models and the importance of
assessing prognostic model performance over the course
of time. Routine recalibration is imperative to adjust for a
changing environment [16, 18, 19]. In their evaluation of
risk models, Harrison et al. [17] found a ‘‘shelf life’’ of
about 3 years before recalibration was required, which is
similar to the approximately 4 years between recalibra-
tion in our study. We advise for the continuous
monitoring of risk models and subsequent recalibration
when an overall recalibration is observed to be worsening.
Pre-control charts provide a comprehensive way to dis-
tinguish genuine worsening from considerable noise by
using yellow (warning) and red (critical) zones. Although
we succeeded in rendering our model stable again by
using the simplest form of recalibration, more rigorous
techniques may sometimes be needed, from recalculating
the coefﬁcients of each individual variable to removing or
adding new variables [18, 19]. While refraining from
repeated model recalibration may not extensively change
the relative ranking among hospitals [20], we have dem-
onstrated that the percentage of hospitals with poorer care
than expected (SMR[1) changed markedly after recali-
bration from 15 to 35%.
An increased number of temporal (and external)
validation studies are needed for users to acquire an
understanding of a model’s behavior over the course of
time in various domains. Important questions to address
include deciding on the required frequency for recali-
brating models, various approaches for recalibration, and
ways to determine the extent of inﬂuence that older
observations should exert when recalibrating models in a
dynamically changing environment. In all of these
efforts, policy implications of model’s performance
should play a central role because the use of these
models requires trust and, in turn, this trust requires an
extensive understanding of the effect of models’ per-
formance on policy decisions.
Conclusion
The Brier scores and SMR of rSAPS-II showed statisti-
cally signiﬁcant differences between expected and
observed values over time, but the AUC did not show this
behavior. Thus, variability patterns over time may
markedly vary among different performance measures,
thereby illustrating the importance of using a set of
measures covering both aspects of model discrimination
and calibration. The worsening of the overall SMR
resulted in an improper assessment of quality of care for
many hospitals. Repeated recalibration of models ade-
quately alleviated these problems. Our ﬁndings stress the
importance of timely recalibrating prognostic models and
the assessment of its performance repeatedly over the
course of time. More temporal (and external) validation
studies are needed to understand models’ behavior over
the course of time in various domains.
Conﬂict of interest The authors declare that they have no com-
peting interests. The authors have full control of all primary data
and agree to allow the journal to review their data if requested.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which
permits any noncommercial use, distribution, and reproduction in
any medium, provided the original author(s) and source are
credited.
45References
1. Lucas PJ, Abu-Hanna A (2009)
Prognostic methods in medicine. Artif
Intell Med 15:105–119
2. Abu-Hanna A, Lucas PJ (2001)
Prognostic models in medicine. AI and
statistical approaches. Methods Inf Med
40:1–5
3. Zimmerman D (1999) Benchmarking:
measuring yourself against the best.
Trustee 52:22–23
4. Zimmerman JE, Alzola C, Von Rueden
KT (2003) The use of benchmarking to
identify top performing critical care
units: a preliminary assessment of their
policies and practices. J Crit Care
18:76–86
5. Moons KG, Royston P, Vergouwe Y,
Grobbee DE, Altman DG (2009)
Prognosis and prognostic research:
what, why, and how? Br Med J
338:b375
6. Wyatt JC (1995) Prognostic models:
clinically useful or quickly forgotten?
Br Med J 311:1539–1541
7. Mallet S, Royston P, Waters R, Dutton
S, Altman DG (2010) Reporting
performance of prognostic models in
cancer: a review. BMC Med 8:21
8. de Rooij SE, Abu-Hanna A, Levi M, de
Jonge E (2007) Identiﬁcation of high-
risk subgroups in very elderly intensive
care unit patients. Crit Care 11:R33
9. Le Gall JR, Lemeshow S, Saulnier F
(1993) A new Simpliﬁed Acute
Physiology Score (SAPS II) based on a
European/North American multicenter
study. JAMA 270:2957–2963
10. de Jonge E, Bosman RJ, van der Voort
PH, Korsten HH, Scheffer GJ, de
Keizer NF (2003) Intensive care
medicine in the Netherlands,
1997–2001. I. Patient population and
treatment outcome. Ned Tijdschr
Geneeskd 147:1013–1017
11. Altman DG, Vergouwe Y, Royston P,
Moons KG (2009) Prognosis and
prognostic research: validating a
prognostic model. Br Med J 338:b605
12. Altman DG (1990) Practical statistics
for medical research. Chapman and
Hall, London
13. Fleis J, Levin B, Paik M (2003)
Statistical methods for rates and
proportions. J Wiley, New York
14. Wheeler JW (2004) Advanced topics in
statistical process control. SPC Press,
Knoxville
15. Kramer AA (2005) Predictive mortality
models are not like ﬁne wine. Crit Care
9:636–637
16. Le Gall JR, Neumann A, Hemery F,
Bleriot JP, Fulgencio JP, Garrigues B
et al (2005) Mortality prediction using
SAPS II: an update for French intensive
care units. Crit Care 9:R645–R652
17. Harrison DA, Brady AR, Parry GJ,
Carpenter JR, Rowan K (2006)
Recalibration of risk prediction models
in a large multicenter cohort of
admissions to adult, general critical care
units in the United Kingdom. Crit Care
Med 34:1378–1388
18. Steyerberg EW (2009) Clinical
Prediction Models. A practical
approach to development, validation,
and updating. Springer, New York
19. Steyerberg EW, Borsboom GJ, van
Houwelingen HC, Eijkemans MJ,
Habbema JD (2004) Validation and
updating of predictive logistic
regression models: a study on sample
size and shrinkage. Stat Med
23:2567–2586
20. Bakhshi-Raiez F, Peek N, Bosman RJ,
de Jonge E, de Keizer NF (2007) The
impact of different prognostic models
and their customization on institutional
comparison of intensive care units. Crit
Care Med 35:2553–2560
46